Clinical Trial Update: Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the combination of cyclophosphamide, radiation therapy, and Poly ICLC in patients with unresectable, recurrent, primary, o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Poly-ICLC (poly-ICLC)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Breast Cancer, Colorectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN